DEUTSCHE BANK AG\

Bank

Position in FENC — Fennec Pharmaceuticals Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in FENC

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$310,653

+$180,261 QoQ

Shares Held

28,898

+36.3% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 104 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. FENC ranks #208 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$310,653	28,898	+36.3%	Shares	Defined	2026-08-07
2026-03-31	$130,392	21,202	+22.1%	Shares	Defined	2026-05-06
2025-12-31	$133,710	17,365	-22.2%	Shares	Defined	2026-02-11
2025-06-30	$185,322	22,328	+81.3%	Shares	Defined	2025-08-12
2024-09-30	$61,565	12,313	0.0%	Shares	Defined	2025-06-26
2024-06-30	$75,232	12,313	0.0%	Shares	Defined	2025-06-12
2024-03-31	$136,920	12,313	+8.9%	Shares	Defined	2025-06-02
2023-12-31	$126,909	11,311	+268.7%	Shares	Defined	2024-02-14
2021-06-30	$22,365	3,068	-79.8%	Shares	Defined	2021-08-11
2021-03-31	$94,397	15,201	-8.0%	Shares	Defined	2021-05-13
2020-12-31	$123,125	16,527	+35.2%	Shares	Defined	2021-02-16
2020-09-30	$74,082	12,225	+9.4%	Shares	Defined	2020-11-12
2020-06-30	$93,302	11,174	—	Shares	Defined	2020-08-13
No filing history on record for this holder in this stock.